US Broker Ratings

Moderna, Inc. (MRNA): Investor Outlook Reveals 56% Potential Upside Amidst Volatile Market Conditions

As a key player in the biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) has garnered significant attention from investors, particularly with its innovative messenger RNA (mRNA) technology. Although its stock price..

The Cooper Companies, Inc. (COO) Investor Outlook: Assessing a 26.91% Potential Upside in the Healthcare Sector

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, offers considerable potential for investors seeking exposure to the medical instruments and supplies industry. With a market..

Verona Pharma plc (VRNA) Stock Analysis: A Biotech Gem with 30% Upside Potential

Verona Pharma plc (NASDAQ: VRNA), a promising player in the biotechnology industry, is capturing the attention of investors with its innovative approach to treating respiratory diseases. Headquartered in London, this..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Strong Buy with Potential 71.78% Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) continues to be a compelling choice for investors seeking opportunities within the biotechnology sector. Headquartered in Dublin, Ireland, Jazz specializes in identifying, developing, and commercializing..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a 50% Potential Upside

Investors eyeing the healthcare sector may want to take a closer look at Molina Healthcare Inc (NYSE: MOH), a stalwart in providing managed healthcare services under Medicaid and Medicare programs...

Waters Corporation (WAT): Investor Outlook Highlights 11% Potential Upside in Healthcare Sector

Waters Corporation (NYSE: WAT), a stalwart in the healthcare sector, has caught the attention of investors with its promising analytical workflow solutions, which are making significant impacts across the globe...

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Capitalizing on a 14.83% Potential Upside

Investors eyeing the healthcare sector have a promising candidate in GE HealthCare Technologies Inc. (NYSE: GEHC), currently trading at $76.07. With an impressive potential upside of 14.83%, the stock is..

Ascendis Pharma (ASND) Investor Outlook: Exploring a 32.83% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND) is drawing considerable attention in the biotechnology sector, not just for its innovative approach to addressing unmet medical needs, but also for the significant upside..

Labcorp Holdings Inc. (LH) Stock Analysis: Unveiling the Potential Upside in the Diagnostics Giant

Labcorp Holdings Inc. (NYSE: LH) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $21.92 billion, Labcorp continues..

Centene Corporation (CNC) Stock Analysis: Exploring a 129.66% Potential Upside in Healthcare

Centene Corporation (NYSE: CNC) stands out in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of $16.58 billion, this U.S.-based company is a significant player..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating a 2.25% Upside with Strategic Market Positioning

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, is a prominent player in the medical distribution industry. With a substantial market cap of $9.33 billion, the company..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 43.96% Potential Upside

Elevance Health, Inc. (NYSE: ELV), a titan in the healthcare plans industry, presents a compelling case for investors seeking substantial upside potential. With a current market capitalization of approximately $78.59..

Pfizer, Inc. (PFE) Stock Analysis: Unpacking a 15.20% Upside Potential Amidst Market Challenges

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to be a focal point for investors seeking stability in an otherwise volatile market. With a market capitalization of..

Dr. Reddy’s Laboratories Ltd (RDY) Investor Outlook: Navigating Growth with a 20.10% Revenue Surge

Dr. Reddy’s Laboratories Ltd (RDY) stands at an intriguing juncture for investors, driven by its robust position in the healthcare sector and a remarkable 20.10% revenue growth. As an established..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Unveiling a 37.87% Potential Upside for Investors

Teva Pharmaceutical Industries Limited (NYSE: TEVA) stands as a formidable player in the healthcare sector, specializing in the development, manufacturing, and distribution of generic and specialty medicines. Headquartered in Tel..

Align Technology, Inc. (ALGN): Investor Outlook Reveals 18% Upside Potential Amid Market Volatility

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector, specializes in medical instruments and supplies. The company, headquartered in Tempe, Arizona, is renowned for its innovative Invisalign..

Incyte Corporation (INCY) Stock Analysis: Evaluating Its Potential Upside and Strong Revenue Growth

Investors eyeing the healthcare sector may want to take a closer look at Incyte Corporation (NASDAQ: INCY), a powerhouse in the biotechnology industry with a market cap of $13.25 billion...

Amgen Inc. (AMGN): Investor Outlook Shows Promising 5.37% Potential Upside

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector and a leading player in the drug manufacturing industry, offers compelling investment prospects for individual investors. With a robust market..

BeOne Medicines Ltd. (ONC): Consensus and Growth Potential in the Biotech Sector

Investors with an eye for biotechnology stocks are closely watching BeOne Medicines Ltd. (ONC), a Swiss-based oncology company that’s making waves with its innovative cancer treatments. With a significant market..

Solventum Corporation (SOLV) Stock Analysis: Assessing Growth Potential in the Healthcare Sector

Solventum Corporation (SOLV), a burgeoning player in the healthcare sector, has been attracting attention with its diverse portfolio and strategic approach to addressing critical patient needs globally. With a current..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds